ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Katja Kaipio; Ping Chen; Pia Roering; Kaisa Huhtinen; Piia Mikkonen; Päivi Östling; Laura Lehtinen; Naziha Mansuri; Taina Korpela; Swapnil Potdar; Johanna Hynninen; Annika Auranen; Seija Grénman; Krister Wennerberg; Sampsa Hautaniemi; Olli Carpén

doi:10.1002/path.5356

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Katja Kaipio, Ping Chen, Pia Roering, Kaisa Huhtinen, Piia Mikkonen, Päivi Östling, Laura Lehtinen, Naziha Mansuri, Taina Korpela, Swapnil Potdar, Johanna Hynninen, Annika Auranen, Seija Grénman, Krister Wennerberg, Sampsa Hautaniemi, Olli Carpén

Wennerberg Group

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

46 Citationer (Scopus)

48 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Journal of Pathology
Vol/bind	250
Udgave nummer	2
Sider (fra-til)	159-169
Antal sider	10
ISSN	0022-3417
DOI	https://doi.org/10.1002/path.5356
Status	Udgivet - 2020

Adgang til dokumentet

10.1002/path.5356

Kaipio_et_al_2019_The_Journal_of_PathologyAccepteret manuskript, 2,2 MB

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, K., Hautaniemi, S., & Carpén, O. (2020). ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors. Journal of Pathology, 250(2), 159-169. https://doi.org/10.1002/path.5356

Kaipio, K, Chen, P, Roering, P, Huhtinen, K, Mikkonen, P, Östling, P, Lehtinen, L, Mansuri, N, Korpela, T, Potdar, S, Hynninen, J, Auranen, A, Grénman, S, Wennerberg, K, Hautaniemi, S & Carpén, O 2020, 'ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors', Journal of Pathology, bind 250, nr. 2, s. 159-169. https://doi.org/10.1002/path.5356

@article{6f0b8b3b1e8d4f81a15bd6964e0004c1,

title = "ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors",

author = "Katja Kaipio and Ping Chen and Pia Roering and Kaisa Huhtinen and Piia Mikkonen and P{\"a}ivi {\"O}stling and Laura Lehtinen and Naziha Mansuri and Taina Korpela and Swapnil Potdar and Johanna Hynninen and Annika Auranen and Seija Gr{\'e}nman and Krister Wennerberg and Sampsa Hautaniemi and Olli Carp{\'e}n",

year = "2020",

doi = "10.1002/path.5356",

language = "English",

volume = "250",

pages = "159--169",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "JohnWiley & Sons Ltd",

number = "2",

}

TY - JOUR

T1 - ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

AU - Kaipio, Katja

AU - Chen, Ping

AU - Roering, Pia

AU - Huhtinen, Kaisa

AU - Mikkonen, Piia

AU - Östling, Päivi

AU - Lehtinen, Laura

AU - Mansuri, Naziha

AU - Korpela, Taina

AU - Potdar, Swapnil

AU - Hynninen, Johanna

AU - Auranen, Annika

AU - Grénman, Seija

AU - Wennerberg, Krister

AU - Hautaniemi, Sampsa

AU - Carpén, Olli

PY - 2020

Y1 - 2020

U2 - 10.1002/path.5356

DO - 10.1002/path.5356

M3 - Journal article

C2 - 31595974

SN - 0022-3417

VL - 250

SP - 159

EP - 169

JO - Journal of Pathology

JF - Journal of Pathology

IS - 2

ER -